van den Broek M - Search Results

1

Immunoproteasomes largely replace constitutive proteasomes during an antiviral and antibacterial immune response in the liver.

Khan S, van den Broek M, Schwarz K, de Giuli R, Diener PA, Groettrup M. Khan S, et al. Among authors: van den broek m. J Immunol. 2001 Dec 15;167(12):6859-68. doi: 10.4049/jimmunol.167.12.6859. J Immunol. 2001. PMID: 11739503 Free article.

2

Role of virus and host variables in virus persistence or immunopathological disease caused by a non-cytolytic virus.

Moskophidis D, Battegay M, van den Broek M, Laine E, Hoffmann-Rohrer U, Zinkernagel RM. Moskophidis D, et al. Among authors: van den broek m. J Gen Virol. 1995 Feb;76 ( Pt 2):381-91. doi: 10.1099/0022-1317-76-2-381. J Gen Virol. 1995. PMID: 7531218

3

Perforin dependence of natural killer cell-mediated tumor control in vivo.

van den Broek MF, Kägi D, Zinkernagel RM, Hengartner H. van den Broek MF, et al. Eur J Immunol. 1995 Dec;25(12):3514-6. doi: 10.1002/eji.1830251246. Eur J Immunol. 1995. PMID: 8566046

4

Lactate dehydrogenase-elevating virus (LDV): lifelong coexistence of virus and LDV-specific immunity.

van den Broek MF, Spörri R, Even C, Plagemann PG, Hänseler E, Hengartner H, Zinkernagel RM. van den Broek MF, et al. J Immunol. 1997 Aug 15;159(4):1585-8. J Immunol. 1997. PMID: 9257815

5

The proteasome inhibitor lactacystin prevents the generation of an endoplasmic reticulum leader-derived T cell epitope.

Gallimore A, Schwarz K, van den Broek M, Hengartner H, Groettrup M. Gallimore A, et al. Among authors: van den broek m. Mol Immunol. 1998 Jul;35(10):581-91. doi: 10.1016/s0161-5890(98)00053-4. Mol Immunol. 1998. PMID: 9823757

6

IL-4 and IL-10 antagonize IL-12-mediated protection against acute vaccinia virus infection with a limited role of IFN-gamma and nitric oxide synthetase 2.

van Den Broek M, Bachmann MF, Köhler G, Barner M, Escher R, Zinkernagel R, Kopf M. van Den Broek M, et al. J Immunol. 2000 Jan 1;164(1):371-8. doi: 10.4049/jimmunol.164.1.371. J Immunol. 2000. PMID: 10605032 Free article.

7

The use of LCMV-specific T cell hybridomas for the quantitative analysis of MHC class I restricted antigen presentation.

Schwarz K, van den Broek M, de Giuli R, Seelentag WW, Shastri N, Groettrup M. Schwarz K, et al. Among authors: van den broek m. J Immunol Methods. 2000 Apr 3;237(1-2):199-202. doi: 10.1016/s0022-1759(99)00236-7. J Immunol Methods. 2000. PMID: 10725463 No abstract available.

8

The selective proteasome inhibitors lactacystin and epoxomicin can be used to either up- or down-regulate antigen presentation at nontoxic doses.

Schwarz K, de Giuli R, Schmidtke G, Kostka S, van den Broek M, Kim KB, Crews CM, Kraft R, Groettrup M. Schwarz K, et al. Among authors: van den broek m. J Immunol. 2000 Jun 15;164(12):6147-57. doi: 10.4049/jimmunol.164.12.6147. J Immunol. 2000. PMID: 10843664 Free PMC article.

9

CD8(+) T cells secreting type 2 lymphokines are defective in protection against viral infection.

Wirth S, van den Broek M, Frossard CP, Hügin AW, Leblond I, Pircher H, Hauser C. Wirth S, et al. Among authors: van den broek m. Cell Immunol. 2000 May 25;202(1):13-22. doi: 10.1006/cimm.2000.1639. Cell Immunol. 2000. PMID: 10873302

10

Overexpression of the proteasome subunits LMP2, LMP7, and MECL-1, but not PA28 alpha/beta, enhances the presentation of an immunodominant lymphocytic choriomeningitis virus T cell epitope.

Schwarz K, van Den Broek M, Kostka S, Kraft R, Soza A, Schmidtke G, Kloetzel PM, Groettrup M. Schwarz K, et al. Among authors: van den broek m. J Immunol. 2000 Jul 15;165(2):768-78. doi: 10.4049/jimmunol.165.2.768. J Immunol. 2000. PMID: 10878350 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

436 results

Search Page

Filters